Study of Cyclosporine in the Treatment of Dry Eye Syndrome (ST-603-005)

Efficacy of 0.05% Cyclosporin Eye Drop in Stevens Johnson Syndrome Patient With Chronic Dry Eye

NCT01488396 ·Status: COMPLETED ·Phase: PHASE4

Efficacy of 0.05% Cyclosporine A Eye Drops Combined With Absorbable Tear Duct Plugs in the Treatment of Dry Eye in Sjögren's Syndrom

NCT07171710 ·Status: ENROLLING_BY_INVITATION ·Phase: NA

Efficacy of Topical Cyclosporine 0.05% in the Prevention of Ocular Surface Inflammation Secondary to Pterygia

NCT00383396 ·Status: COMPLETED ·Phase: PHASE4

Safety Study of the Use of Topical Cyclosporine in the Treatment of Dry Eye Disease

NCT02004067 ·Status: COMPLETED ·Phase: PHASE4

NOVA22007 0.05% and 0.1% Cyclosporine Versus Vehicle for the Treatment of Dry Eye

NCT00739349 ·Status: COMPLETED ·Phase: PHASE2

Safety, PK and Efficacy Study of SJP-0132 in Subjects With Dry Eye Disease

NCT04139122 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Study of Two Formulations of Cyclosporine Ophthalmic Emulsion in Healthy Volunteers and in Patients With Dry Eye

NCT01319773 ·Status: COMPLETED ·Phase: PHASE1

Investigation of Maintaining Visual Performance Achieved With Cyclosporine Therapy

NCT02121847 ·Status: COMPLETED ·Phase: PHASE4

Microvascular and Inflammatory Responses of 0.05 Cyclosporine Eye Drop (II) in Treatment of Dry Eye

NCT05131152 ·Status: UNKNOWN ·Phase: NA

Study of SkQ1 as Treatment for Dry-eye Syndrome

NCT03764735 ·Status: COMPLETED ·Phase: PHASE3

Efficacy of Topical Cyclosporine Versus Tears for Improving Visual Outcomes Following Multifocal IOL Implantation

NCT00349583 ·Status: COMPLETED ·Phase: PHASE4

Comparing Effect of Topical Tacrolimus 0.03% Versus Cyclosporine 0.05% in Dry Eyes of Secondary Sjogren Syndrome

NCT03865888 ·Status: COMPLETED ·Phase: PHASE3

Cyclosporine 0.05% Eye Drops for Vernal Keratoconjunctivitis Trial

NCT05353101 ·Status: COMPLETED ·Phase: PHASE1

A Clinical Study Evaluating the Safety and Efficacy of SI-614 Ophthalmic Solution in Patients With Dry Eye

NCT01558999 ·Status: COMPLETED ·Phase: PHASE2

Phase 3 Study of OTX-101 in the Treatment of Keratoconjunctivitis Sicca

NCT02688556 ·Status: COMPLETED ·Phase: PHASE3

A Randomized, Parallel-Group Comparison Study of Topical Corticosteroids in Dry Eye Patients With Sjögren Syndrome

NCT02011776 ·Status: COMPLETED

Efficacy of Cyclosporine Ophthalmic Emulsion in the Treatment of Dry Eye Syndrome in Contact Lens Wearers

NCT00335114 ·Status: COMPLETED ·Phase: NA

A Multi-Center Study Subjects With Dry Eye Syndrome

NCT01745887 ·Status: COMPLETED ·Phase: PHASE1

A Prospective, Randomized, Placebo and Active Comparator Controlled Study of CP-690,550 in Subjects With Dry Eye.

NCT00784719 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Study to Evaluate the Safety, Tolerability, and Efficacy of OTX-CSI in Subjects With Dry Eye Disease.

NCT04362670 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Cyclosporine A in the TReatment of Interstitial Pneumonitis Associated With Sjogren's Syndrome

NCT02370550 ·Status: UNKNOWN ·Phase: PHASE4

A Study of the Efficacy and Safety of Cyclosporin Ophthalmic Gel in Subjects With Moderate to Severe Dry Eye Disease

NCT06766357 ·Status: RECRUITING ·Phase: PHASE3

Study of SY-201 Ophthalmic Solution in Subjects With Dry Eye Disease

NCT05370495 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Cyclosporine 0.1% / Loteprednol 0.2% Effect on Anterior Segment Normalization

NCT05322148 ·Status: COMPLETED ·Phase: PHASE3

Cyclosporine and Intense Pulsed Light for Dry Eye in Contact Lens Users

NCT06392438 ·Status: RECRUITING ·Phase: PHASE3